<DOC>
	<DOCNO>NCT01860040</DOCNO>
	<brief_summary>To determine rate pathologic complete response ( pCR ) time definitive surgical resection non-small cell lung cancer ( NSCLC )</brief_summary>
	<brief_title>Neoadjuvant Chemo NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1 . Patients ≥ 18 year age either mass suspicious histologically confirm AJCC stage IBIIIA NSCLC . For without histologic confirmation NSCLC , biopsy do patient histologically confirm NSCLC meeting eligibility criterion may proceed protocol . 2 . Mass must determine surgically resectable 3 . Eastern Cooperative Oncology Group ( ECOG ) performance status score &lt; 1 life expectancy &gt; 3 month . 4 . Participants must least one evaluable lesion define RECIST 1.1 5 . Absolute neutrophil count &gt; 1500 mm3 , platelet count ≥ 100×109 L , hemoglobin ≥ 8.5 g/dL 6 . Serum creatinine ≤1.3 mg/dL ( candidate cisplatin chemotherapy ) , total bilirubin ≤ 2 mg/dL , AST/ALT ≤ 5 time upper limit normal range 7 . No prior chemotherapy radiotherapy NSCLC 8 . At least 5 year diagnosis another cancer except treat insitu disease surgically resect nonmelanoma skin cancer clear margin . 9 . Willingness provide permission biopsy NSCLC collection frozen pretreatment sample . 10 . Women childbearing potential ( i.e. , woman premenopausal surgically sterile ) must willing use acceptable contraceptive method ( abstinence , oral contraceptive double barrier method ) duration study 30 day follow last dose study drug , must negative urine serum pregnancy test within 2 week prior begin treatment trial 1 . Active clinically serious infection &gt; CTCAE ( version 4.03 ) Grade 2 . 2 . Serious nonhealing wound , ulcer , bone fracture . 3 . Major contraindication surgical resection NSCLC 4 . Inability complete inform consent process adhere protocol treatment plan followup requirement . 5 . Concurrent severe illness active infection , psychiatric illness/social situation would limit safety compliance study requirement . 6 . Patients receive investigational agent . 7 . Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>